International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13332 - 13332
Published: Aug. 28, 2023
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
associated
with
mitochondrial
damage.
Circulating
metabolites
may
be
elevated
in
NAFLD
but
their
associations
damage
not
known.
This
study
aimed
to
assess
the
association
of
key
degree
fibrosis
context
and
nonalcoholic
steatohepatitis
(NASH).
Cross-sectional
analyses
were
performed
on
two
cohorts
biopsy-proven
and/or
NASH
subjects.
The
circulating
metabolite
concentrations
was
assessed
using
linear
regression
analysis.
In
single-center
cohort
subjects
(n
=
187),
mean
age
54.9
±13.0
years,
40.1%
female
86.1%
White.
Type
2
diabetes
(51.3%),
hypertension
(43.9%)
obesity
(72.2%)
prevalent.
Those
high
citrate
had
a
higher
proportion
moderate/significant
(stage
F
≥
2)
(68.4
vs.
39.6%,
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13381 - 13381
Published: Aug. 29, 2023
Diabetes
mellitus
is
a
chronic
multifaceted
disease
with
multiple
potential
complications,
the
treatment
of
which
can
only
delay
and
prolong
terminal
stage
disease,
i.e.,
type
2
diabetes
(T2DM).
The
World
Health
Organization
predicts
that
will
be
seventh
leading
cause
death
by
2030.
Although
many
antidiabetic
medicines
have
been
successfully
developed
in
recent
years,
such
as
GLP-1
receptor
agonists
SGLT-2
inhibitors,
single-target
drugs
are
gradually
failing
to
meet
therapeutic
requirements
owing
individual
variability,
diversity
pathogenesis,
organismal
resistance.
Therefore,
there
remains
need
investigate
pathogenesis
T2DM
more
depth,
identify
targets,
provide
improved
glycemic
control
solutions.
This
review
presents
an
overview
mechanisms
action
development
latest
agents
targeting
years.
It
also
discusses
emerging
target-based
therapies
new
targets
emerged
within
last
three
aim
our
theoretical
basis
for
further
advancement
targeted
T2DM.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(1), P. 217 - 217
Published: Jan. 16, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
the
most
common
chronic
worldwide
and
affects
nearly
30%
of
adult
population
10%
pediatric
population.
It
estimated
that
this
number
will
double
by
2030.
MASLD
one
leading
causes
hepatocellular
carcinoma,
cirrhosis,
transplantation,
as
well
a
significant
risk
factor
for
cardiovascular
mortality.
Due
to
ever-increasing
patients,
long-term
asymptomatic
course
disease,
serious
complications,
lack
preventive
programs,
insufficient
awareness
among
patients
doctors
themselves,
growing
interdisciplinary
problem
real
challenge
modern
medicine.
The
main
cause
an
inappropriate
lifestyle—inadequate
nutrition
physical
activity,
which
lead
various
components
metabolic
syndrome.
Lifestyle
changes—appropriate
diet,
weight
reduction,
systematic
activity—are
also
basis
prevention
treatment
MASLD.
Hence,
in
recent
years,
so
much
importance
has
been
attached
lifestyle
medicine,
non-pharmacological
diseases.
narrative
review
presents
possible
therapeutic
options
management
best
documented
available
diets
used
were
discussed,
focusing
on
benefits
drawbacks
Mediterranean,
high-protein,
ketogenic,
intermittent
fasting
diets.
In
addition,
recommendations
regarding
activity
are
summarized.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3120 - 3120
Published: July 12, 2023
The
ketogenic
diet
(KD)
is,
nowadays,
considered
an
interesting
nutritional
approach
for
weight
loss
and
improvement
in
insulin
resistance.
Nevertheless,
most
of
the
studies
available
literature
do
not
allow
a
clear
distinction
between
its
effects
on
sensitivity
per
se,
induced
by
KDs
sensitivity.
In
this
review,
we
discuss
scientific
evidence
direct
mediated
glycemic
status
humans,
describing
KD's
biochemical
background
underlying
mechanisms.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(1), P. 61 - 61
Published: Jan. 1, 2024
This
review
provides
a
practical
and
comprehensive
overview
of
non-pharmacological
interventions
for
metabolic-associated
fatty
liver
disease
(MASLD),
focusing
on
dietary
exercise
strategies.
It
highlights
the
effectiveness
coffee
consumption,
intermittent
fasting,
Mediterranean
ketogenic
diets
in
improving
metabolic
health.
The
emphasizes
importance
combining
aerobic
resistance
training
as
critical
approach
to
reducing
fat
increasing
insulin
sensitivity.
Additionally,
it
discusses
synergy
between
diet
enhancing
parameters
role
gut
microbiota
MASLD.
paper
underscores
need
holistic,
individualized
approach,
integrating
diet,
exercise,
health,
patient
motivation.
also
long-term
benefits
minimal
risks
lifestyle
compared
side
effects
pharmacological
surgical
options.
calls
personalized
treatment
strategies,
continuous
education,
further
research
optimize
therapeutic
outcomes
MASLD
management.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(21), P. 15788 - 15788
Published: Oct. 31, 2023
Due
to
their
beneficial
effects
in
an
array
of
diseases,
Mesenchymal
Stromal
Cells
(MSCs)
have
been
the
focus
intense
preclinical
research
and
clinical
implementation
for
decades.
MSCs
multilineage
differentiation
capacity,
support
hematopoiesis,
secrete
pro-regenerative
factors
exert
immunoregulatory
functions
promoting
homeostasis
resolution
injury/inflammation.
The
main
include
modulation
immune
cells
(macrophages,
neutrophils,
lymphocytes),
secretion
antimicrobial
peptides,
transfer
mitochondria
(Mt)
injured
cells.
These
actions
can
be
enhanced
by
priming
(i.e.,
licensing)
prior
exposure
deleterious
microenvironments.
Preclinical
evidence
suggests
that
therapeutic
a
variety
pathological
states,
including
cardiac,
respiratory,
hepatic,
renal,
neurological
diseases.
One
key
emerging
is
improvement
mitochondrial
tissues
enhancing
quality
control
(MQC).
Recent
advances
understanding
cellular
MQC,
biogenesis,
mitophagy,
fission,
fusion,
helped
uncover
how
enhance
these
processes.
Specifically,
suggested
regulate
peroxisome
proliferator-activated
receptor-gamma
coactivator
1
alpha
(PGC1α)-dependent
Parkin-dependent
Mitofusins
(Mfn1/2)
or
Dynamin
Related
Protein-1
(Drp1)-mediated
fission/fusion.
In
addition,
previous
studies
also
verified
from
through
tunneling
nanotubes
via
microvesicular
transport.
Combined,
improve
functions,
thereby
contributing
injury
inflammation.
Thus,
uncovering
affect
MQC
opens
new
avenues
organ
injury,
transplantation
MSC-derived
might
represent
attractive
approach.
Journal of the International Society of Sports Nutrition,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Jan. 29, 2024
Background
The
effect
of
low-carbohydrate
high-fat
dietary
manipulation,
such
as
the
ketogenic
diet
(KD),
on
muscle
strength
assessment
in
resistance-training
(RT)
participants
has
focused
one-repetition
maximum
test
(1-RM).
However,
a
pre-specified
1-RM
value
during
an
exercise
training
program
disregards
several
confounding
factors
(i.e.
sleep,
diet,
and
training-induced
fatigue)
that
affect
exerciser's
"true"
load
daily
preparedness.
We
aimed
to
evaluate
6-week
RT
control-related
variables
trained
subjects
following
KD
intervention.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(16), P. 4857 - 4857
Published: Aug. 17, 2024
The
prevalence
of
nonalcoholic
fatty
liver
disease
(NAFLD)
is
likely
to
be
approaching
38%
the
world's
population.
It
predicted
become
worse
and
main
cause
morbidity
mortality
due
hepatic
pathologies.
particularly
worrying
that
NAFLD
increasingly
diagnosed
in
children
closely
related,
among
other
conditions,
insulin
resistance
metabolic
syndrome.
Against
this
background
concern
awareness
patients
with
low;
one
study,
almost
96%
adult
USA
were
not
aware
their
disease.
Thus,
studies
on
therapeutic
tools
used
treat
are
extremely
important.
One
promising
treatment
a
well-formulated
ketogenic
diet
(KD).
aim
paper
present
review
available
publications
current
state
knowledge
effect
KD
NAFLD.
This
includes
characteristics
key
factors
(from
point
view
regression),
which
exerts
its
effects,
i.e.,
reduction
body
weight,
elimination
fructose
monosaccharides,
limitation
total
carbohydrate
intake,
anti-inflammatory
ketosis
state,
or
modulation
gut
microbiome
metabolome.
In
context
evidence
for
effectiveness
regression
NAFLD,
also
suggests
important
role
taking
responsibility
one's
own
health
through
increasing
self-monitoring
self-education.
Current Treatment Options in Psychiatry,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Nov. 21, 2024
This
review
explores
the
evidence
for
using
a
ketogenic
diet
as
transdiagnostic
treatment
mental
health
disorders.
We
examine
biological
pathophysiologic
mechanisms
that
underlie
many
neuropsychiatric
disorders—such
mitochondrial
dysfunction,
oxidative
stress,
inflammation,
glucose
hypometabolism,
and
glutamate/GABA
imbalance—that
can
be
ameliorated
by
diet.
Additionally,
literature
summarizes
clinical
trials
case
reports
on
various
psychiatric
Recent
research
provides
may
an
effective
schizophrenia/schizoaffective
disorder,
bipolar
depression,
anxiety
disorders,
Alzheimer's
disease,
autism
spectrum
somatic
eating
alcohol
use
disorder.
Many
disorders
have
shared
metabolic
pathways
exacerbate
or
cause
psychopathology.
The
is
not
only
address
but
also
ameliorate
symptoms
like
anxiety,
mania,
psychosis,
cognitive
impairment.
These
effects
suggest
has
potential
to
serve
non-pharmacological
option
ease
global
disease
burden
of
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3167 - 3167
Published: July 17, 2023
Body
composition
changes
that
occur
during
aging,
such
as
loss
of
lean
mass,
are
unfavorable
at
metabolic
level
and
they
can
explain,
in
part,
the
appearance
certain
age-associated
diseases
type
2
diabetes
(T2D).
Separately,
T2D
is
associated
with
an
increase
oxidative
stress
(OS)
which
negatively
affects
skeletal
muscle.
Our
aim
was
to
study
differences
clinical
nutritional
parameters,
disease
control,
OS
a
cohort
older
patients
classified
according
amount
mass
had.
We
included
100
adults
than
65
years
T2D.
found
women
low
fat-free
muscle
have
worse
control.
Moreover,
percentile
present
high
value
OS.
The
shows
presence
(LM)
geriatric
population
diagnosed
poorer
glycemic
control
greater